Kura Oncology(KURA)
SAN DIEGO, CABiotechnology
Focus: Kura Oncology is a San Diego-based public biotech focused on small-molecule oncology therapeutics, currently advancing a portfolio of early-stage programs across hematologic malignancies and solid tumors. The company operates as a clinical-stage player with meaningful cash position and active trial expansion.
Profile data last refreshed 59m ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
9-3 this month
Stable — net -3 jobs in 30d
5 added, 8 removed. Backfill posture.
Should You Work at Kura Oncology?
AI assessmentKura is a clinical-stage biotech with meaningful pipeline depth and capital efficiency, suitable for early-career scientists and clinical professionals willing to take execution risk in exchange for potential upside.
Why Work Here
- Strong pipeline momentum with 20 active trials spanning Phase 1–3, including Phase 3 data catalyst on Ziftomenib in AML—a high-impact hematologic indication.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT04809233Expanded Access to Tipifarnib
N/AHelp build intelligence for Kura Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.